Skip to main content
. 2023 Feb 23;15(5):1425. doi: 10.3390/cancers15051425

Figure 2.

Figure 2

Number of molecular and cytogenetic risk defining alteration according to ELN2022 and distribution acrooss ELN2022 prognostic risk group.